Start of epSOS Pilot Operation

Over more than three years, the members of the epSOS project, cofunded by the European Commission, have invested hours of hard work as well as enthusiasm into the development of feasible cross-border eHealth services, addressing technical, semantic and legal interoperability challenges. These tremendous efforts have now finally culminated in the large scale pilot entering into operational mode.

On the 13th of April 2012, the epSOS piloting phase has started, testing the technical, semantic and legal solutions that have been developed in the epSOS project in a real-life environment over a one-year period. This means that from now on, European patients that have agreed to take part in the epSOS pilot and epSOS health professionals will be using and evaluating the epSOS pilot cross-border Patient Summary, ePrescription and eDispensation services at points of care participating in the epSOS pilot. The intention is to demonstrate the concept that, with the help of epSOS, medical treatment for citizens residing in other countries can be improved by providing health professionals with the necessary patient data in a secure electronic format.

The major challenge for secure cross border data exchange in respect of EU and national privacy regulations has been successfully addressed in a common approach accepted by the participating nations. It has then been implemented through national contractual arrangements which are based on the epSOS Framework Agreement. The protection of personal data will be systematically monitored during the operation of the services, to ensure continuing conformance and protection throughout the epSOS pilot.

Visit www.epsos.eu/poc_database now to find healthcare provider participating in the epSOS pilot phase.

For further information, please visit: http://www.epsos.eu

About epSOS
epSOS aims to design, build and evaluate a service infrastructure that demonstrates cross-border interoperability between electronic health record systems in Europe.

Most Popular Now

Open Call HORIZON-JU-IHI-2022-03-05: Dig…

Mental health disorders represent an area of severe unmet public health need. This has been further negatively impacted by the COVID-19 pandemic, with a substantial increase in the number and...

The Future of Medicine is Data

At the 2023 Annual J.P. Morgan Healthcare Conference, Owkin Co-founder and CEO Thomas Clozel, MD will outline how data is the future of medicine - from the development of new...

Young People Want Trustworthy Mental Hea…

Young people may not be receiving the mental health support they need because of a lack of trust in the smartphone apps that deliver such services, a study suggests. Questions about...

Brain Area Necessary for Fluid Intellige…

A team led by UCL and UCLH researchers have mapped the parts of the brain that support our ability to solve problems without prior experience - otherwise known as fluid...

Study Surveys Landscape of Apps Built on…

A study led by Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, is among the first to survey the current landscape of FHIR® apps, providing a snapshot of how...

New Computer Program 'Learns' to Identif…

Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because they exist...

Allscripts Announces Corporate Name Chan…

Allscripts Healthcare Solutions, Inc. announced that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand...

Applications Open for SpinLab Accelerato…

The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the...

Bayer to Accelerate Drug Discovery with …

Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run...

220M€ Investment in Testing and Experime…

To make the EU the place where AI excellence thrives from the lab to the market, the European Union is setting up world-class Testing and Experimentation Facilities (TEFs) for AI. Together...

Artificial Nerve Cells - Almost Like Bio…

Researchers at Linköping University (LiU), Sweden, have created an artificial organic neuron that closely mimics the characteristics of biological nerve cells. This artificial neuron can stimulate natural nerves, making it...

AI Tool Developed to Predict Risk of Lun…

Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and...